Company intelligence
Cytospire Therapeutics Ltd
Cytospire Therapeutics is developing a portfolio of next generation immune cell engagers
Biotechnology Research
27 employees
3 public signals
Verified activity
Signals from Cytospire Therapeutics Ltd
3 published signals
People
Cytospire Therapeutics Ltd welcomed Dr Sumeet Ambarkhane, MD as Chief Medical Officer.
Reported by Cytospire Therapeutics Ltd
Products & Services
Cytospire Therapeutics Ltd is preparing for the first-in-human trial for the lead program CYT X300 (EGFR-gamma-delta bispecific engager) in solid tumours.
Reported by Dr Sumeet Ambarkhane, MD
People
Cytospire Therapeutics Ltd appointed Dr Sumeet Ambarkhane, MD as Chief Medical Officer.
Reported by Dr Sumeet Ambarkhane, MD